EUVIMEDEUVIMED entdecken
Crossref

Hesperidin Methyl Chalcone Inhibits Hallmarks of Cancer by Targeting the AKT, PI3K/GSK‐3β/β‐Catenin/STAT3 Signaling Axis in Oral Squamous Cell Carcinoma Models

Saranya Jawaharlal iD, Ramachandhiran Duraisamy, Vinothkumar Veerasamy iD

Journal of Biochemical and Molecular Toxicology · 2026-06 · 40 (6)

DOI: 10.1002/jbt.70966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 18.06.2026. Verfasst von Saranya Jawaharlal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamilnadu, India. Hauptthemen laut MEDLINE: Mouth Neoplasms, STAT3 Transcription Factor, beta Catenin, Glycogen Synthase Kinase 3 beta. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) is the most prevalent and drug‐resistant cancer. We studied the chemopreventive effects of Hesperidin Methyl Chalcone (HMC) on DMBA‐induced hamster buccal pouch carcinogenesis (HBPCs). Male golden Syrian hamsters developed oral tumors on their left buccal pouches after being treated with 0.5% DMBA topically three times a week for 10 weeks. These findings suggest that well‐developed squamous cell carcinomas were highly differentiated, exhibiting hyperplasia and dysplasia. Hamsters with DMBA‐painted buccal mucosal tissue were treated with HMC, which greatly improved the biochemical and histological changes. In addition, in silico analysis was performed to anticipate possible protein targets for this medication, including Akt, Pi3k, GSk‐3β, β‐catenin, and STAT3. HMC has a high binding affinity to the above proteins. The current study reveals that HMC has strong chemopreventive properties and protects the Akt, Pi3k, GSk‐3β, β‐catenin, and STAT3 proteins, which were considerably changed during DMBA‐induced oral carcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsSTAT3 Transcription Factorbeta CateninGlycogen Synthase Kinase 3 betaCarcinoma, Squamous CellSignal TransductionProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHesperidinChalconesAnimalsMaleMesocricetusCricetinae9,10-Dimethyl-1,2-benzanthracene

Stichwörter der Autor:innen

biochemicaldysplasiahyperplasiain silicooral carcinogenesis

Substanzen

STAT3 Transcription Factorbeta CateninGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHesperidinChalcones9,10-Dimethyl-1,2-benzanthracene

Autor:innen und Institutionen

  • Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamilnadu, India.

ORCID-Profile: Saranya Jawaharlal, Vinothkumar Veerasamy

Zitieren

APA

Jawaharlal, S., Duraisamy, R., & Veerasamy, V. (2026). Hesperidin Methyl Chalcone Inhibits Hallmarks of Cancer by Targeting the AKT, PI3K/GSK‐3β/β‐Catenin/STAT3 Signaling Axis in Oral Squamous Cell Carcinoma Models. Journal of Biochemical and Molecular Toxicology, 40(6). https://doi.org/10.1002/jbt.70966

Vancouver

Jawaharlal S, Duraisamy R, Veerasamy V. Hesperidin Methyl Chalcone Inhibits Hallmarks of Cancer by Targeting the AKT, PI3K/GSK‐3β/β‐Catenin/STAT3 Signaling Axis in Oral Squamous Cell Carcinoma Models. Journal of Biochemical and Molecular Toxicology. 2026;40(6). doi:10.1002/jbt.70966

BibTeX
@article{Jawaharlal2026,
  author = {Jawaharlal, Saranya and Duraisamy, Ramachandhiran and Veerasamy, Vinothkumar},
  title = {Hesperidin Methyl Chalcone Inhibits Hallmarks of Cancer by Targeting the AKT, PI3K/GSK‐3β/β‐Catenin/STAT3 Signaling Axis in Oral Squamous Cell Carcinoma Models},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1002/jbt.70966}
}
Kostenlos starten →